Under construction – not a live service

Skip to content

Frontlight Research

Trial site

Toronto

Toronto, Ontario, CanadaNot linked to an institution yet

0running trials
4closed trials
0trials confirmed by the site in the last 60 days
–languages not stated

The site has not confirmed any trial yet.

Running trials

No running trial is registered here.

Researchers

No researcher is linked here yet.

Closed trials

Completed
A Safety and Preliminary Efficacy Study of CC-99282 in Combination With Obinutuzumab in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
NCT04434196· Phase 1· Source
Terminated
A Safety and Efficacy Study of CC-90009 Combinations in Subjects With Acute Myeloid Leukemia
NCT04336982· Phase 1· Source
Terminated
A Dose-finding Study of CC-90009 in Subjects With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher-risk Myelodysplastic Syndromes
NCT02848001· Phase 1· Source
Completed
An Efficacy and Safety Study of AG-221 (CC-90007) Versus Conventional Care Regimens in Older Subjects With Late Stage Acute Myeloid Leukemia Harboring an Isocitrate Dehydrogenase 2 Mutation
NCT02577406· Phase 3· Source

Site data: ClinicalTrials.govUpdated 3 Nov 2026

Report an error